Burg G - Search Results

1

Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis.

Hauschild A, Weichenthal M, Balda BR, Becker JC, Wolff HH, Tilgen W, Schulte KW, Ring J, Schadendorf D, Lischner S, Burg G, Dummer R. Hauschild A, et al. Among authors: burg g. J Clin Oncol. 2003 Aug 1;21(15):2883-8. doi: 10.1200/JCO.2003.07.116. J Clin Oncol. 2003. PMID: 12885805 Clinical Trial.

2

Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha?

Urosevic M, Oberholzer PA, Maier T, Hafner J, Laine E, Slade H, Benninghoff B, Burg G, Dummer R. Urosevic M, et al. Among authors: burg g. Clin Cancer Res. 2004 Aug 1;10(15):4959-70. doi: 10.1158/1078-0432.CCR-04-0193. Clin Cancer Res. 2004. PMID: 15297396

3

Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma.

Cozzio A, Kempf W, Schmid-Meyer R, Gilliet M, Michaelis S, Schärer L, Burg G, Dummer R. Cozzio A, et al. Among authors: burg g. Leuk Lymphoma. 2006 May;47(5):865-9. doi: 10.1080/10428190500399698. Leuk Lymphoma. 2006. PMID: 16753871 Clinical Trial.

4

Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients.

Murer K, Urosevic M, Willers J, Selvam P, Laine E, Burg G, Dummer R. Murer K, et al. Among authors: burg g. Melanoma Res. 2004 Aug;14(4):257-62. doi: 10.1097/01.cmr.0000136713.21029.56. Melanoma Res. 2004. PMID: 15305155

5

Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy.

Heinzerling L, Burg G, Dummer R, Maier T, Oberholzer PA, Schultz J, Elzaouk L, Pavlovic J, Moelling K. Heinzerling L, et al. Among authors: burg g. Hum Gene Ther. 2005 Jan;16(1):35-48. doi: 10.1089/hum.2005.16.35. Hum Gene Ther. 2005. PMID: 15703487 Clinical Trial.

6

Expression of melanoma-associated antigens in melanoma cell cultures.

Urosevic M, Braun B, Willers J, Burg G, Dummer R. Urosevic M, et al. Among authors: burg g. Exp Dermatol. 2005 Jul;14(7):491-7. doi: 10.1111/j.0906-6705.2005.00305.x. Exp Dermatol. 2005. PMID: 15946236

7

Detection of melanoma relapse: first comparative analysis on imaging techniques versus S100 protein.

Beyeler M, Waldispuhl S, Strobel K, Joller-Jemelka HI, Burg G, Dummer R. Beyeler M, et al. Among authors: burg g. Dermatology. 2006;213(3):187-91. doi: 10.1159/000095034. Dermatology. 2006. PMID: 17033166

8

Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation.

Kamarashev J, Theler B, Dummer R, Burg G. Kamarashev J, et al. Among authors: burg g. Int J Dermatol. 2007 Sep;46(9):930-5. doi: 10.1111/j.1365-4632.2007.03149.x. Int J Dermatol. 2007. PMID: 17822495

9

Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient.

Heinzerling L, Dummer R, Burg G, Schmid-Grendelmeier P. Heinzerling L, et al. Among authors: burg g. Eur J Dermatol. 2002 Mar-Apr;12(2):194-7. Eur J Dermatol. 2002. PMID: 11872423

10

Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand.

Willers J, Dummer R, Kempf W, Kündig T, Burg G, Kadin ME. Willers J, et al. Among authors: burg g. Clin Cancer Res. 2003 Jul;9(7):2744-54. Clin Cancer Res. 2003. PMID: 12855655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

651 results

Search Page

Filters